Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Initially the hypothalamic factor responsible for the release of corticotropin (CRF), was thought to be a simple peptide. More recent work has led to the conclusion that CRF is a multifactorial complex. In 1979 we proposed that vasopressin, much disputed as a CRF candidate, was a major constituent of the complex, interacting with a potentiating the CRF activity of the other component(s). The recent characterization of a 41 residue ovine hypothalamic peptide capable of releasing adrenocorticotropic hormone (ACTH) in a dose-related manner has allowed us to compare its CRF bioactivity with that of vasopressin and simple extracts of the hypothalamus, and to investigate any interaction it may have with vasopressin and other hypothalamic factors in the release of ACTH. We report here that the new CRF is more potent than vasopressin in releasing ACTH. When given simultaneously with vasopressin a fourfold potentiation of CRF activity with steep dose-response characteristics were observed. It also potentiated vasopressin-free hypothalamic extracts, suggesting that a new CRF does not account for all the nonvasopressin portion of the CRF complex.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Their synergistic stimulation of ACTH production and secretion by corticotrope cells could yield a several-fold higher output than due to the action of either one individually (26, 34–41, 43–47).”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [36]
In the citing paper
“Namely, it has been indicated that both CRH and AVP act on their own receptors (28–32) on corticotrope cells in anterior pituitary to stimulate adrenocorticotropic hormone (ACTH) production and release with different (26, 33–41) or even similar potencies (42).”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [36]
In the citing paper
“Namely, both in human (39, 43–47, 55) and in rat (26, 36–38, 40, 41), CRH reaction pathway is considered to be dominant in pituitary-adrenal regulation.”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [36]
In the citing paper
“Corticotropin-releasing hormone and AVP interact at the level of the anterior pituitary (16)”
From Progesterone does not alter osmotic regulation of AVP (2001) · cites this paper as [16]
In the citing paper
“Furthermore, VP stimulates adrenocorticotropin hormone release through the activation of pituitary V1bR [10,11].”
From Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats (2015) · cites this paper as [10]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
VALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Schally, A. V., Arimura, A., & Kastin, A. J. (1973) · Science · doi:10.1126/science.179.4071.341 · Cited by 572
Frontiers in Neuroendocrinology
Ball, J. B. (1975) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197501000-00019 · Cited by 426
FRONTIERS IN NEUROENDOCRINOLOGY
Kennedy, G. C. (1970) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.33.5.719 · Cited by 357
Corticotrophin releasing factor may be modulated vasopressin
GILLIES, G., & LOWRY, P. (1979) · Nature · doi:10.1038/278463a0 · Cited by 174
Self-citationHypothalamic Releasing Factors
Burgus, R. C., & Guillemin, R. (1970) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.39.070170.002435 · Cited by 129
Gillies, G. E., & Lowry, P. J. (1978) · Endocrinology · doi:10.1210/endo-103-2-521 · Cited by 106
Self-citationZimmerman, E. A., Stillman, M. A., Recht, L. D., Antunes, J. L. F., Carmel, P. W., & Goldsmith, P. C. (1977) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1977.tb41872.x · Cited by 97
Gillies, G. E., Greidanus, T. B. V. W., & Lowry, P. J. (1978) · Endocrinology · doi:10.1210/endo-103-2-528 · Cited by 60
Self-citation
Research works printed but not linked: 5
- Royce, P. C. & Sayers, G. Proc. Soc. exp. Biol. Med. 142, 842–845 (1960).
- Gillies, G. & Lowry, P. J. in Interactions within the Brain-Pituitary-Adrenocortical System (eds Jones, Gilham, Dallman & Chattopadhyay) 51–61 (Academic, New York, 1979).
- Sokol, H. W. & Zimmerman, E. A. Ann. N.Y. Acad. Sci. (in the press).
- Zimmerman, E. A. in Frontiers of Neuroendocrinology Vol. 4 (eds Martini, L. & Ganong, W. F.) 25–62 (Raven, New York, 1976).
- Baertischi, A. in Neuroendocrinology of Vasopressin, Corticoliberin and Opiomelanocortin (eds Baertischi, A. & Driefuss, J.-J.) (Academic, London, in the press).
Cited by
Items 901–971 of 971
Measurement and Function of Neuropeptides
Koob, G. F., & Bissette, G. (1989) · Springer eBooks · doi:10.1007/978-1-4899-0906-0_13
Adaptive (Hypothalamic) and Innate Immunoregulation
Berczi, I., Quintanar‐Stephano, A., & Kovács, K. (2011) · Advances in Neuroimmune Biology · doi:10.3233/nib-2011-028
“The effect of VP on CRH mediated ACTH release is either synergistic or additive (Table 2) [80, 81].”
BackgroundKlampfl, S. M. (2015) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.31369
Papel da corticosterona na vigência do estresse sobre a função pineal em ratos.
Moraes, R. C. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2010.tde-18102010-153227 · Cited by 1
Amador‐Arjona, A. (2008) · Repositori digital de la UPF (Universitat Pompeu Fabra)
The hypothalamic anterior pituitary relationships and their tumors
VanGilder, J. C. (1988) · Surgical Neurology · doi:10.1016/0090-3019(88)90271-6
Vasopressin in the brain and plasma of the aging rat : a radioimmunoassay study
Terwel, D. (1992) · Research Publications (Maastricht University) · doi:10.26481/dis.19921105dt
Corticotropin‐Releasing Factora
Jennes, L. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb16171.x
“Original magnifications: (1) ~ 8 2 ; (2) ~ 5 3 0 ; (3) ~ 7 0 ; (4) ~ 1 3 0 (5) X490: all have been reduced by 30%.”
Ein Hormon stellt sich vor: Copeptin (CT-pro AVP), ein neuer Biomarker
Hacker, N., & Obermayer-Pietsch, B. M. (2014) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Corticosteroids and anti-inflammatory drugs
Deutschman, C. S. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511781933.052
ACTH Secreting Pituitary Adenomas
Raffin‐Sanson, M., de Keyzer, Y., & BERTAGNA, X. Y. (2002) · Springer eBooks · doi:10.1007/978-1-4615-1103-8_7
Effets ergogéniques, métaboliques et hormonaux des glucocorticoïdes chez l'homme et l'animal
Thomasson, R. (2011) · theses.fr (ABES) · doi:10.70675/9d73bc9czbb03z4cd4zbf68z901fa5bd4fda · Cited by 1
Taveau, C. (2014) · theses.fr (ABES) · doi:10.70675/ae70a073z3913z427azadb3z150d685f522f · Cited by 1
“Endocrinology 2011 Sep; 52(9):34923503”
Bäckström, T. (2008) · Uppsala University Publications (Uppsala University)
Aberrante Rezeptorexpression bei Patienten mit primärem Hyperaldosteronismus
Suttmann, Y. (2011) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.13224
Role of Kappa-Opioid Receptors in Stress-Induced Behaviors
Veer, V. S., & Victoria, A. (2013) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Fan, S. (2006) · UC Research Repository (University of Canterbury) · doi:10.26021/7257
Differential Regulation of ACTH and β-Endorphin by Controlled Processing
Ham, J., & Smyth, D. G. (1986) · Springer eBooks · doi:10.1007/978-1-4684-5131-3_24
Corticotropin Releasing Factor (Hormone): Physiological and Clinical Implications
Chrousos, G. P., Udelsman, R., Gold, P. W., Margioris, A. N., Oldfield, E. H., Schürmeyer, T. H., Schulte, H. M., Doppman, J. L., & Loriaux, D. L. (1989) · Neuroendocrine perspectives · doi:10.1007/978-1-4612-3554-5_2
The Effect of VIP on Progesterone (PROG) Release in Dehydrated Male Rats
Wasilewska-Dziubińska, E., Radzikowska, M., & Baranowska, B. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb07009.x
3 of Hypothalamic Neurons by Behavioral Stress
Silverman, A., Hou-Yu, A., & Kelly, D. D. (1989)
Füchsl, A. M. (2015) · University of Regensburg Publication Server (University of Regensburg)
Fink, G. (1987) · Basic and clinical aspects of neuroscience · doi:10.1007/978-3-642-69950-4_7
The Overlap Between Romantic Love And Addiction
Barends, A. J. (2014) · Utrecht University Repository (Utrecht University) · Cited by 1
Carroll, J. A. (1993) · OakTrust (Texas A&M University Libraries) · Cited by 1
van Bysterveldt, K. A. (2011) · UC Research Repository (University of Canterbury) · doi:10.26021/7130
“, 1995; Rivier & Vale, 1983) and in vitro (Evans et al., 1996; Gilllies et al., 1982), and occurs in all mammalian models tested.”
BackgroundItoi, K. (2005) · Folia Pharmacologica Japonica · doi:10.1254/fpj.126.174
Quinze Ans Après : l'urocortine vient damer le pion du CRF
Vaudry, H. (1996) · médecine/sciences · doi:10.4267/10608/728
“Ainsi, comme les Trois Mousquetaires, les neuropeptides hypothalamiques qui exercent un contrôle direct de l’activité des cellules corticotropes sont maintenant au nombre de quatre, à savoir la vasopressine [6], le CRF [1], un peptide dérivé du précurseur de la pro-thyrolibérine [7, 8] (m/s n°11, vol.”
BackgroundEffects of soy isoflavones on the hypothalamic-pituitary system in rats: a morphofunctional study
Trifunović, S. L. (2012) · doi:10.2298/bg20120710trifunovic · Cited by 1
Calefi, A. S. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.10.2016.tde-07102016-124200 · Cited by 2
Prévide, R. M. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2017.tde-07032017-135154
Secretion of CRF-41, AVP and SRIF by Fetal Hypothalamic Neurons Cultured in Defined Medium
Gillies, G. E., & Clarke, M. (1989) · Neuroendocrine perspectives · doi:10.1007/978-1-4612-3478-4_35
Self-citationD’Costa, N. (2019) · UWSpace (University of Waterloo)
Adrenal Insufficiency, “Relative Adrenal Insufficiency,” or None of the Above?
Vamvini, M. T., & Hennessey, J. V. (2019) · Springer eBooks · doi:10.1007/978-3-030-22720-3_12
Anterior Pituitary and Pars Intermedia Space
Romanò, N., & Shipston, M. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813814-4.00008-0 · Cited by 3
Hug, E. (2020) · edoc (University of Basel) · doi:10.5451/unibas-ep83589
No role of vasopressin in stress-induced ACTH secretion?
Mormède, P. (1984) · Nature · doi:10.1038/308086a0
(1986) · International review of cytology · doi:10.1016/s0074-7696(08)61916-6
Kannan, C. R. (1987) · Springer eBooks · doi:10.1007/978-1-4613-1849-1_8
(1989) · Elsevier eBooks · doi:10.1016/b978-0-12-510310-7.50013-2
Jensen, I. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9601
Raby, W. N., Heller, M., Milliaressis, D., Choi, C. J., Basaraba, C. N., LEVIN, F. R., Church, S., Pavlicová, M., & Nunes, E. V. (2023) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2023.100158
Ramadhan, H., Syafitri, A., Irsyad, M. A., & Nasution, M. D. (2023) · Asian Australasian Neuro and Health Science Journal (AANHS-J) · doi:10.32734/aanhsj.v5i2.12347
“Posttranslational processing separates AVP, copeptin, and neurophysin 2 during transport down the infundibulum to axon terminals in the posterior pituitary, where AVP is stored in neurosecretory granules until specific osmotic and nonosmotic stimuli cause secretion into the circulation [7,8].”
BackgroundInfluentialTijani, O. K. (2024) · theses.fr (ABES) · doi:10.70675/fb776aaez39eez41a6za2c3zfca980d80ab3
Nikaj, A., Atila, C., Chifu, I. O., Ferrante, E., Erlic, Z., Drummond, J., Indirli, R., Drexhage, R. C., Powlson, A., Gurnell, M., et al. (2025) · Endocrine Abstracts · doi:10.1530/endoabs.110.p931
Kokoris, J. Č., Milošević, V., & Stevanović, D. (2025) · Journal of Medical Biochemistry · doi:10.5937/jomb0-61972
“Ghrelin in vivo has a stimulatory effect on the hypothalamic-pituitary-adrenal (HPA) axis (35) and on ACTH release, due to the synergistic action of corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) from the hypothalamus (36).”
Plasticity and neuromodulation of neuroendocrine nerve terminals
Iremonger, K. J. (2025) · Journal of Neuroendocrinology · doi:10.1111/jne.70110
“71,72 As such, upregulation of vasopressin synthesis and release is one mechanism by which HPA axis output can be increased during times of high demand.”
Stojiljković, A., Čupić, Ž., Maćešić, S. R., Ivanović-Šašić, A., & Mojović, M. (2025) · Royal Society Open Science · doi:10.1098/rsos.251323
Riesco-Lopez, J. M., Vázquez, R., Carretero, J., Méndez, J. A. J., Rubio, M., Blanco, E. J., Asensio, M., & Riesco, J. M. (2009) · Gredos (University of Salamanca)
Neira, S. (2023) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/jp9x-7455
The influence of habitual fluid intake on energy balance
NC DOCKS at The University of North Carolina at Greensboro, & Zaplatosch, M. E. (2023) · NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro)
Thorsdottir, D. (2021) · ScholarWorks -A service of University of Vermont Libraries (University of Vermont)
Jollin, L. (2011) · theses.fr (ABES) · doi:10.70675/17518e5fzf149z4921z8de5z1b4644ae7f2c · Cited by 2
Caractérisation d’outils pharmacologiques pour l’étude des récepteurs centraux de la vasopressine
Marir, R. (2013) · theses.fr (ABES) · doi:10.70675/547ee25cz6fbfz417azabc9z92de6a7a2fcc
Conséquences pharmacologiques et fonctionnelles de l'hétérodimérisation des récepteurs V1B et CRF1
Mion, J. (2013) · theses.fr (ABES) · doi:10.70675/91d47531z8447z44d1z9f7ezf39a8e060318
Watanasriyakul, W. T. (2026) · Developmental Psychobiology · doi:10.1002/dev.70158 · Cited by 1
James, S. M., Marinelli, I., Pons, T., Romanò, N., Tabak, J., Campos, P., & Walker, J. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.07.723482
“AVP and CRH act synergistically to enhance ACTH secretion [24, 25].”
Itoi, K. (2026) · Endocrine Journal · doi:10.1507/endocrj.ej20260203
“CRF and AVP are both potent secretagogues for ACTH, with an in vitro study showing they stimulate its release from the anterior pituitary synergistically [25].”
Weisenseel, Z., & Glasper, E. R. (2026) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2026.101328
“Although AVP alone is a relatively weak secretagogue of ACTH, it markedly potentiates CRH-induced ACTH release – by more than four-fold – likely through suppression of background TWIK-related potassium (TREK-1) channel activity in pituitary corticotrophs (Gillies et al., 1982; Lee et al., 2015).”
Andrews, L., El Khaldi, Y., George, T., Abuhamdah, T., & Knezevic, N. N. (2026) · Brain Sciences · doi:10.3390/brainsci16101071
Ireland, C. (2026) · Papyrus : Institutional Repository (Université de Montréal) · doi:10.71781/36300
The Hypothalamus–Pituitary Axis
Gasco, V., Prencipe, N., & Grottoli, S. (2026) · Endocrinology · doi:10.1007/978-3-319-27318-1_12-2
BindingDB (2012) · UC San Diego · doi:10.7270/q20v8bbw
BindingDB Entry 50038932: Tetrahydroquinoline sulfonamides as vasopressin 1b receptor antagonists.
BindingDB (2012) · UC San Diego · doi:10.7270/q2j9679w
Dunham, L. A. (2015) · Digital Archive @ GSU · doi:10.57709/7011118
Perani, C. V. (2014) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.30044 · Cited by 1
Heuser, I., Bissette, G., Dettling, M., Schweiger, U., Gotthardt, U., Schmider, J., Lammers, C.-H., Nemeroff, C. B., & Holsboer, F. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)8:2<71::aid-da5>3.0.co;2-n
“Studies in both laboratory animals and humans have provided evidence that arginine-vasopressin (AVP) is able to potentiate the ACTH-stimulating effects of CRH at the pituitary [16–19].”
Background
Metadata
- Authors
- Gillies, G. E., Linton, E. A., & Lowry, P. J.
- Affiliations
- St Bartholomew's Hospital (GB)
- ORCID
- Linton, E. A.
- Venue
- Nature
- Published
- 1982-09
- Volume
- 299
- Issue
- 5881
- Pages
- 355-357
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2088159839
- Cited by
- 965
- References
- 20
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 6 · 2023: 10 · 2022: 12 · 2021: 7 · 2020: 12 · 2019: 16 · 2018: 10 · 2017: 16 · 2016: 20 · 2015: 12 · 2014: 20 · 2013: 16 · 2012: 17
- FWCI
- 12.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- corticotropin-releasing factor, vasopressin, hypothalamic neuropeptides, hypothalamic extract, hypothalamic-pituitary-adrenal axis
- MeSH terms
- Adrenocorticotropic Hormone, Animals, Corticotropin-Releasing Hormone, Dose-Response Relationship, Drug, Drug Synergism, Hypothalamus, Vasopressins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.